On Tuesday, December 19, 2023, the President signed into law: H.R. 1734, the “Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023” or the “TRANQ Research Act of 2023,” which requires the Department of Commerce’s National Institute of Standards and Technology to support research and other activities related to identifying xylazine, novel synthetic opioids,…
Search Results
Search results for: “xylazine”
The Administration’s Actions
Read about recent actions taken by the Biden-Harris Administration:
Dr. Rahul Gupta Releases Statement on CDC’s New Overdose Death Data
Washington, D.C. – Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), issued the following statement regarding the CDC’s release of provisional drug overdose death data, which show 109,680 predicted overdose deaths in the 12-month period ending in December 2022. Most of these deaths were caused by illicit synthetic…
Steering Committee Meeting of the Canada-United States Joint Action Plan on Opioids
The following joint statement was released by the Governments of Canada and the United States of America Canada and the United States are committed to combatting the devastating overdose crisis and the toxic illegal drug supply driving it. Through the Joint Action Plan on Opioids (OAP), our two countries continue to work jointly on public…
Dr. Rahul Gupta Releases Statement on DOJ’s New Drug Enforcement Actions
Washington, D.C. – Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), issued the following statement regarding the Administration actions announced today to stop fentanyl trafficking. “The actions announced today by the Departments of Justice and Treasury highlight President Biden’s call in his State of the Union to accelerate…
Dr. Rahul Gupta Releases Statement on CDC’s New Overdose Death Data Showing a Full Year of Flattening Overdose Deaths
As the Biden-Harris Administration works to fully implement President Biden’s National Drug Control Strategy, U.S. is seeing continued progress after a full year of flattening overdose deaths, halting period of rapid increases from 2019 – 2021 Washington, D.C. – Today, White House Office of National Drug Control Policy (ONDCP) Director Dr. Rahul Gupta issued the following…
Remarks by ONDCP Director Dr. Rahul Gupta at the National Conference of State Legislatures 2023 Summit
Dr. Gupta brings President Biden’s Unity Agenda message and urgent call to action to nation’s largest gathering of legislators and legislative staff Indianapolis, IN – Today, White House Office of National Drug Control Policy (ONDCP) Director Dr. Rahul Gupta delivered remarks at the National Conference of State Legislatures (NCSL) Annual Legislative Summit in Indianapolis, Indiana.…
ONDCP Director Statement on New CMS Guidance to Increase Access to Addiction Treatment in Carceral Facilities
Historic new guidance allows states to apply to use their federal Medicaid funds to support reentry—a time when individuals with substance use disorder are at higher risk for overdose death Washington, D.C. – Dr, Rahul Gupta, the Director of the White House Office of National Drug Control Policy (ONDCP), issued the following statement regarding the…
A Proclamation on Overdose Awareness Week, 2023
The overdose epidemic is a national crisis, and for millions of Americans, it is personal. Too many families have lost their children, siblings, parents, and friends to substance misuse and overdose. Every loss is a painful reminder that we must take bold action to end our Nation’s overdose epidemic. During Overdose Awareness Week, we reaffirm…
White House Challenge to Save Lives from Overdose
America’s overdose crisis impacts all of us. Families in small towns, large cities, Tribal lands, and every community in between are affected, no matter who they are, what they look like, or how much money they make. That’s why President Biden named beating the opioid and overdose crisis a key pillar of his Unity Agenda…
